| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | — | -2.1% |
| R&D Expense | $621K | — | +6.9% |
| SG&A Expense | $525K | — | -23.1% |
| Operating Income | $31K | — | +122.9% |
| Pre-tax Income | -$756K | — | +17.9% |
| Income Tax | $0 | — | — |
| Net Income | -$756K | — | +17.9% |
| EPS (Basic) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.4M | -8.8% | +37.6% |
| Accounts Receivable | $1.3M | +29.5% | -7.8% |
| Inventory | $523K | +29.8% | +36.4% |
| Current Assets | $3.4M | +6.8% | +11.8% |
| Total Assets | $4.8M | +3.2% | +22.4% |
| Current Liabilities | $47.5M | +1.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$126K | — | -144.0% |
| Capital Expenditures | $9K | — | +757.9% |
| Investing Cash Flow | -$9K | — | +53.1% |
| Free Cash Flow | -$135K | — | -147.4% |
| +6.1% |
| Total Liabilities | $48.4M | +1.6% | +7.3% |
| Stockholders' Equity | -$43.6M | -1.4% | -5.9% |